Table 2 Economic features of the included studies

Type of economic evaluation

CEA

21

70

CUA

5

17

CBA

4

13

Study design

RCT

8

27

Quasi-experimental

3

10

Modelling

6

20

Observational (prospective, retrospective etc.)

13

43

Perspective evaluated

Societal

0

0

Government

3

10

Healthcare system/Healthcare provider

23

77

Third party

2

7

Patients

1

3

Mixed

1

3

Type of sensitivity analysis

One-way analysis

5

17

Multi-way analysis

1

3

Univariate/multivariate regression

1

3

Probabilistic analysis

1

3

Not performed

22

73

Time horizon

<= 1 year

8

27

1-10 years

5

17

Over 10 years

5

17

Not specified

12

40

Type of outcome

QALY/DALY

5

17

Intermediate (physiological, functional, etc.)

21

70

Monetary

4

13

Level of care and intervention type

Primary prevention

2

7

Curative (Surgical/Medical procedure)

10

33

Curative (Pharmaceuticals)

7

23

Diagnostic/screening (secondary prevention)

10

33

Mode of delivery of care

1

3

Type of data used

Primary data

22

73

Secondary data

4

13

Mixed

4

13

Type of costs included

Direct medical costs

30

100

Direct non-medical costs

4

13

Indirect costs (Productivity loss)

0

0